Report of Foreign Issuer (6-k)
September 22 2016 - 7:42AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT
OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE
13a-16 or 15d-16
UNDER
THE SECURITIES EXCHANGE ACT
of 1934
For the month of September 2016
001-37521
(Commission File Number)
INTEC PHARMA LTD.
(Translation of registrant’s name into
English)
12 Hartom Street
Har Hotzvim, Jerusalem 9777512, Israel
(+972) (2) 586-4657
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F
x
Form
40-F
¨
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(l): _________
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): _________
In
connection with the
notice furnished by the Company on Form 6-K on September 9, 2016 regarding
the publication in two Israeli newspapers of a Notice of Special General Meeting of Shareholders, the company hereby announces
that the record date of the meeting shall be
Monday, September 26, 2016
and not as previously announced. The meeting
will take place as scheduled on October 18, 2016.
The
Company's proxy solicitation materials for distribution in the United States will be furnished separately on or about September
29, 2016.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
INTEC PHARMA LTD.
|
|
|
|
|
By:
|
/s/ Zeev Weiss
|
|
|
Name: Zeev Weiss
|
|
|
Title: Chief Executive Officer
|
|
|
|
Date: September 22, 2016
|
|
|
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Intec Parent (NASDAQ:NTEC)
Historical Stock Chart
From Sep 2023 to Sep 2024